Skip to main content
Clinical Trials/JPRN-UMIN000005025
JPRN-UMIN000005025
Not Yet Recruiting
N/A

Examination of treatment utility and advantage of taking medicine in which acknowledgment function improvement in patient with schizophrenia with new antipsychotic is made main axis - Examination of treatment utility and advantage of taking medicine in which acknowledgment function improvement in patient with schizophrenia with new antipsychotic is made main axis

Department of Psychiatry,Kobe University Graduate School of Medicine0 sites60 target enrollmentMarch 1, 2011
Conditionsschizophrenia

Overview

Phase
N/A
Intervention
Not specified
Conditions
schizophrenia
Sponsor
Department of Psychiatry,Kobe University Graduate School of Medicine
Enrollment
60
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Psychiatry,Kobe University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • In case of patients with diabetic mellitus is excluded because Olanzapine is contraindicated drug.

Outcomes

Primary Outcomes

Not specified

Similar Trials